Healthcare provider profile · identity verified

Aaron Smuckler

Internal Medicine · PITTSBURGH, PA · NPI 1144232406

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	548	179
Amlodipine Besylate	Amlodipine Besylate	335	99
Lisinopril	Lisinopril	334	110
Levothyroxine Sodium	Levothyroxine Sodium	281	75
Pantoprazole Sodium	Pantoprazole Sodium	250	83
Rosuvastatin Calcium	Rosuvastatin Calcium	206	72
Metoprolol Succinate	Metoprolol Succinate	203	65
Losartan Potassium	Losartan Potassium	181	61
Gabapentin	Gabapentin	179	55
Eliquis	Apixaban	169	46
Fluticasone Propionate	Fluticasone Propionate	166	52
Omeprazole	Omeprazole	165	49
Furosemide	Furosemide	161	53
Hydrochlorothiazide	Hydrochlorothiazide	156	48
Carvedilol	Carvedilol	148	44
Metoprolol Tartrate	Metoprolol Tartrate	147	38
Tamsulosin Hcl	Tamsulosin Hcl	144	54
Metformin Hcl	Metformin Hcl	126	35
Simvastatin	Simvastatin	120	34
Jardiance	Empagliflozin	118	33
Trazodone Hcl	Trazodone Hcl	118	32
Potassium Chloride	Potassium Chloride	115	40
Prednisone	Prednisone	112	89
Alendronate Sodium	Alendronate Sodium	111	36
Meloxicam	Meloxicam	110	44
Ozempic	Semaglutide	107	20
Bupropion Xl	Bupropion Hcl	97	17
Pregabalin	Pregabalin	95	22
Glipizide Er	Glipizide	91	29
Escitalopram Oxalate	Escitalopram Oxalate	90	27
Albuterol Sulfate Hfa	Albuterol Sulfate	88	33
Celecoxib	Celecoxib	83	32
Clopidogrel	Clopidogrel Bisulfate	81	23
Famotidine	Famotidine	79	32
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	79	21
Metformin Hcl Er	Metformin Hcl	77	27
Allopurinol	Allopurinol	74	24
Amitriptyline Hcl	Amitriptyline Hcl	74	19
Azelastine Hcl	Azelastine Hcl	74	28
Mirtazapine	Mirtazapine	66	18
Pravastatin Sodium	Pravastatin Sodium	66	21
Trulicity	Dulaglutide	66	12
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	65	14
Duloxetine Hcl	Duloxetine Hcl	64	21
Valsartan	Valsartan	63	19
Venlafaxine Hcl Er	Venlafaxine Hcl	63	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	62	16
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	60	19
Mounjaro	Tirzepatide	60	12
Montelukast Sodium	Montelukast Sodium	59	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	57	15
Oxycodone Hcl	Oxycodone Hcl	57	19
Spironolactone	Spironolactone	55	17
Sertraline Hcl	Sertraline Hcl	53	17
Xultophy 100-3.6	Insulin Degludec/Liraglutide	53	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	51	16
Finasteride	Finasteride	50	15
Fluoxetine Hcl	Fluoxetine Hcl	50	19
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	47	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	46	20
Synthroid	Levothyroxine Sodium	44	13
Doxazosin Mesylate	Doxazosin Mesylate	42	suppressed
Hydralazine Hcl	Hydralazine Hcl	42	13
Donepezil Hcl	Donepezil Hcl	36	suppressed
Xarelto	Rivaroxaban	36	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	33	suppressed
Ibuprofen	Ibuprofen	33	15
Warfarin Sodium	Warfarin Sodium	33	12
Baclofen	Baclofen	32	12
Atenolol	Atenolol	31	11
Fluconazole	Fluconazole	31	14
Sumatriptan Succinate	Sumatriptan Succinate	31	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	30	29
Tradjenta	Linagliptin	30	suppressed
Alprazolam	Alprazolam	29	suppressed
Lorazepam	Lorazepam	29	20
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	29	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	28	12
Tramadol Hcl	Tramadol Hcl	28	15
Cephalexin	Cephalexin	27	18
Isosorbide Mononitrate Er	Isosorbide Mononitrate	27	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	27	20
Lansoprazole	Lansoprazole	25	suppressed
Bumetanide	Bumetanide	23	suppressed
Citalopram Hbr	Citalopram Hydrobromide	23	suppressed
Hydrocortisone	Hydrocortisone	23	13
Incruse Ellipta	Umeclidinium Bromide	23	suppressed
Meclizine Hcl	Meclizine Hcl	23	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	23	suppressed
Clonazepam	Clonazepam	22	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	22	suppressed
Nystatin	Nystatin	22	13
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	21	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	21	20
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	21	suppressed
Colchicine	Colchicine	20	13
Irbesartan	Irbesartan	20	suppressed
Lactulose	Lactulose	20	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	20	12
Metolazone	Metolazone	19	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	18	15
Clobetasol Propionate	Clobetasol Propionate	18	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	18	suppressed
Propranolol Hcl Er	Propranolol Hcl	17	suppressed
Valacyclovir	Valacyclovir Hcl	16	13
Amoxicillin	Amoxicillin	15	11
Buspirone Hcl	Buspirone Hcl	15	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	15	suppressed
Farxiga	Dapagliflozin Propanediol	15	suppressed
Glipizide	Glipizide	15	suppressed
Rizatriptan	Rizatriptan Benzoate	15	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Azithromycin	Azithromycin	14	14
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	14	suppressed
Lovastatin	Lovastatin	14	suppressed
Methylprednisolone	Methylprednisolone	14	14
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Ondansetron Odt	Ondansetron	14	suppressed
Ventolin Hfa	Albuterol Sulfate	14	suppressed
Verapamil Er	Verapamil Hcl	14	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Diclofenac Sodium	Diclofenac Sodium	13	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Ibandronate Sodium	Ibandronate Sodium	12	suppressed
Methadone Hcl	Methadone Hcl	12	suppressed
Methenamine Hippurate	Methenamine Hippurate	12	suppressed
Nitroglycerin Patch	Nitroglycerin	12	suppressed
Olanzapine	Olanzapine	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Raloxifene Hcl	Raloxifene Hcl	12	suppressed
Temazepam	Temazepam	12	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	12	suppressed
Febuxostat	Febuxostat	11	suppressed
Humalog Kwikpen U-200	Insulin Lispro	11	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Klor-Con M20	Potassium Chloride	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Tresiba Flextouch U-100	Insulin Degludec	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error